Real-world experience of esketamine use to manage treatment-resistant depression: A multicentric study on safety and effectiveness (REAL-ESK study)
Giovanni Martinotti, Massimo di Giannantonio(ASST Melegnano e della Martesana), Ileana Andriola(University of Bari Aldo Moro), Marco Di Nicola, Alberto Siracusano(University of Rome Tor Vergata), Stefania Di Mauro, Sergio Barlati(Institut thématique Génétique, génomique et bioinformatique), Antonello Bellomo(University of Foggia), Mauro Pettorruso(University of Chieti-Pescara), Massimo Clerici(University of Milano-Bicocca), Sergio De Filippis(Villa Melitta), Antonio Vita(University of Brescia), Gianluca Rosso(Neuroscience Institute), Vassilis Martiadis, Andrea Fagiolini(University of Siena), Giuseppe Maina(University of Turin), Gabriele Sani, Roberta Bassetti, Andreas Conca(Ospedale di Bolzano), Bernardo Dell’Osso(University of Milan), Roger S. McIntyre(University Health Network), Sandro Belletti, Giorgio Di Lorenzo(University of Rome Tor Vergata), Pasquale De Fazio(Magna Graecia University), Giacomo d’Andrea(University of Chieti-Pescara), Miriam Olivola, Alessandro Valchera, Giuseppe Nicolò(ASL Roma), Roberto Delle Chiaie(Sapienza University of Rome), Domenica Nucifora, Alessandro Bertolino(University of Bari Aldo Moro)
Cited by 130
Related Papers
A longitudinal study on the mental health of general population during the COVID-19 epidemic in China
|Brain Behavior and Immunity|2020|2.7k
How mental health care should change as a consequence of the COVID-19 pandemic
|The Lancet Psychiatry|2020|1.9k
Canadian Network for Mood and Anxiety Treatments (<scp>CANMAT</scp>) and International Society for Bipolar Disorders (<scp>ISBD</scp>) 2018 guidelines for the management of patients with bipolar disorder
|Bipolar Disorders|2018|1.8k
COVID-19 Pandemic and Lockdown Measures Impact on Mental Health Among the General Population in Italy
|Frontiers in Psychiatry|2020|1.4k